MAHL.Y Stock Overview
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
MediPal Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥18.00 |
| 52 Week High | JP¥19.07 |
| 52 Week Low | JP¥14.03 |
| Beta | 0.014 |
| 1 Month Change | 14.29% |
| 3 Month Change | 28.34% |
| 1 Year Change | n/a |
| 3 Year Change | 7.85% |
| 5 Year Change | -1.85% |
| Change since IPO | 54.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| MAHL.Y | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 10.1% | -1.9% | -0.3% |
| 1Y | n/a | -12.5% | 8.0% |
Return vs Industry: Insufficient data to determine how MAHL.Y performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how MAHL.Y performed against the US Market.
Price Volatility
| MAHL.Y volatility | |
|---|---|
| MAHL.Y Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.9% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: MAHL.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MAHL.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1898 | 13,075 | Shuichi Watanabe | www.medipal.co.jp |
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products.
MediPal Holdings Corporation Fundamentals Summary
| MAHL.Y fundamental statistics | |
|---|---|
| Market cap | US$3.54b |
| Earnings (TTM) | US$340.15m |
| Revenue (TTM) | US$25.13b |
10.4x
P/E Ratio0.1x
P/S RatioIs MAHL.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MAHL.Y income statement (TTM) | |
|---|---|
| Revenue | JP¥3.65t |
| Cost of Revenue | JP¥3.40t |
| Gross Profit | JP¥254.21b |
| Other Expenses | JP¥204.78b |
| Earnings | JP¥49.43b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 13, 2025
| Earnings per share (EPS) | 237.68 |
| Gross Margin | 6.96% |
| Net Profit Margin | 1.35% |
| Debt/Equity Ratio | 0% |
How did MAHL.Y perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield25%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/10 23:33 |
| End of Day Share Price | 2025/05/08 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MediPal Holdings Corporation is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Ritsuo Watanabe | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Global Markets Japan Inc. |